Aeolus Pharmaceuticals, Inc.
AOLS
$0.0001
$0.000.00%
| 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | 06/30/2016 | |
|---|---|---|---|---|---|
| Revenue | 771.00K | 1.42M | 1.85M | 2.08M | 2.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 771.00K | 1.42M | 1.85M | 2.08M | 2.46M |
| Cost of Revenue | 2.49M | 2.97M | 2.88M | 2.88M | 2.87M |
| Gross Profit | -1.72M | -1.55M | -1.02M | -805.00K | -403.00K |
| SG&A Expenses | 2.37M | 2.46M | 2.59M | 2.47M | 2.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.87M | 5.44M | 5.47M | 5.35M | 5.15M |
| Operating Income | -4.09M | -4.02M | -3.61M | -3.27M | -2.68M |
| Income Before Tax | -4.09M | -4.02M | -3.61M | -3.56M | -2.97M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.09 | -4.02 | -3.61 | -3.56 | -2.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.09M | -4.02M | -3.61M | -3.56M | -2.97M |
| EBIT | -4.09M | -4.02M | -3.61M | -3.27M | -2.68M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.03 | -0.03 | -0.04 | -0.04 | -0.04 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 |
| EPS Diluted | -0.04 | -0.04 | -0.05 | -0.05 | -0.04 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 |
| Average Basic Shares Outstanding | 608.37M | 607.93M | 607.41M | 594.76M | 578.58M |
| Average Diluted Shares Outstanding | 608.37M | 607.93M | 607.41M | 594.76M | 578.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
